Antonella Putignano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Antonella Putignano has a total of 476 co-authors. Here are the top co-authors by number of shared publications:
- Thierry Gustot
Department of Transplantation and Gastroenterology, Hepato-pancreatology and Digestive Oncology, HUB Hôpital Erasme, Brussels, Belgium; Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium; Université libre de Bruxelles, Brussels, Belgium
7 shared publications Christophe Moreno
5 shared publicationsDelphine Degré
4 shared publications- Rajiv Jalan
Institute for Liver and Digestive Health, University College Hospital, Royal Free Campus, London, UK
4 shared publications - Carmine Gambino
Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine (DIMED), University of Padova, Italy
3 shared publications Frank Erhard Uschner
3 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Elsevier in Journal of Hepatology
Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study
- 1 October 2026
- Published by Elsevier in Journal of Hepatology
Open AccessSurvival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study
- 20 April 2026
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (3) , 449-462
Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis
- 20 April 2026
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (3) , 449-462
Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis
- Top Cited PapersOpen Access
- 21 February 2026
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (1) , 91-105
Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts
- 21 February 2026
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (1) , 91-105
Top Cited PapersOpen AccessDevelopment and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts
- 1 July 2025
- Published by Wolters Kluwer Health in Hepatology
- Vol. 83 (4) , 838-850
Antibody response to microbiota antigens is associated with alcohol-related liver disease severity and predicts mortality
Background and Aims: Alcohol-related liver disease (ALD) is associated with dysbiosis and translocation of gut microbial components, stimulating the innate immunity. The potential role of adaptive immune responses to gut microbiota has been less studied. We hypothesized that microbiota-specific antibody responses could be associated with ALD severity and outcomes. Approach and Results: Two hundred and seven patients with ALD were recruited at a single site and classified as steato-fibrosis, compensated cirrhosis Child–Pugh A, decompensated cirrhosis Child–Pugh B or C without (CP B/C) and with severe alcohol-related hepatitis (sAH). Biophysical and functional characteristics of antibodies specific for 11 classes of microbiota antigens were determined. High-dimensional analyses were used to compare levels and characteristics of antibodies between groups and explore their association with clinical outcomes. ALD severity was associated with increased levels of microbiota-specific antibodies and binding to Fc-gamma-receptors (FcgR), with the strongest relationships observed for levels of Staphylococcus aureus IgA and Candida albicans IgG and for binding of Escherichia coli IgG to FcgRIIb. Additional associations were observed between ALD severity and microbiota-specific antibody effector functions, suggesting regulation of their functional potential. Among patients with CP B/C and sAH, microbiota-specific antibody profiles predicted the occurrence of septic shock and mortality at 90 days, independently of the MELD score. Conclusions: The antibody response to microbiota is associated with ALD severity and predicts the risk of severe outcomes. These results suggest a role for immune complexes in ALD pathogenesis and that antibody profiling has potential as a biomarker for clinical management of ALD patients.
- 1 July 2025
- Published by Wolters Kluwer Health in Hepatology
- Vol. 83 (4) , 838-850
Antibody response to microbiota antigens is associated with alcohol-related liver disease severity and predicts mortality
Background and Aims: Alcohol-related liver disease (ALD) is associated with dysbiosis and translocation of gut microbial components, stimulating the innate immunity. The potential role of adaptive immune responses to gut microbiota has been less studied. We hypothesized that microbiota-specific antibody responses could be associated with ALD severity and outcomes. Approach and Results: Two hundred and seven patients with ALD were recruited at a single site and classified as steato-fibrosis, compensated cirrhosis Child–Pugh A, decompensated cirrhosis Child–Pugh B or C without (CP B/C) and with severe alcohol-related hepatitis (sAH). Biophysical and functional characteristics of antibodies specific for 11 classes of microbiota antigens were determined. High-dimensional analyses were used to compare levels and characteristics of antibodies between groups and explore their association with clinical outcomes. ALD severity was associated with increased levels of microbiota-specific antibodies and binding to Fc-gamma-receptors (FcgR), with the strongest relationships observed for levels of Staphylococcus aureus IgA and Candida albicans IgG and for binding of Escherichia coli IgG to FcgRIIb. Additional associations were observed between ALD severity and microbiota-specific antibody effector functions, suggesting regulation of their functional potential. Among patients with CP B/C and sAH, microbiota-specific antibody profiles predicted the occurrence of septic shock and mortality at 90 days, independently of the MELD score. Conclusions: The antibody response to microbiota is associated with ALD severity and predicts the risk of severe outcomes. These results suggest a role for immune complexes in ALD pathogenesis and that antibody profiling has potential as a biomarker for clinical management of ALD patients.
- 13 March 2022
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 28 (6) , 933-935
Liver Transplantation in Acute‐on‐Chronic Liver Failure Grade 3: Fifty Shades of Gray
- 13 March 2022
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 28 (6) , 933-935
Liver Transplantation in Acute‐on‐Chronic Liver Failure Grade 3: Fifty Shades of Gray
- 28 May 2021
- Published by Wolters Kluwer Health in Hepatology
- Vol. 74 (5) , 2714-2724
Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol‐Associated Liver Disease
Background and Aims: Infection is a major driver of mortality in patients with advanced alcohol‐associated liver disease (ALD). The epidemiology and clinical course of patients infected with life‐threatening forms of ALD, including severe alcohol‐associated hepatitis (sAH) and decompensated alcohol‐associated cirrhosis (DAC), and specific risk factors for infection remain mostly unknown. Approach and Results: In this observational study, we assessed all infectious episodes occurring within a 90‐day period from diagnosis in all consecutive patients with biopsy‐proven sAH (modified Maddrey’s discriminant function ≥ 32, Model for End‐Stage Liver Disease [MELD] ≥ 18) and DAC (MELD ≥ 18) without alcohol‐associated hepatitis in our tertiary hospital between 2003 and 2016. A total of 207 patients were included: 139 with sAH and 68 with DAC. One hundred seventeen (84%) patients with sAH and 41 (60%) patients with DAC experienced at least one infection episode at 90 days (P < 0.001). In multivariable analysis, factors associated with the development of infection were the presence of sAH and baseline MELD score. Bacterial infections represented the most common infection in the two groups, and only the MELD score was independently associated with the occurrence of bacterial infection. In both groups, pneumonia was the most prevalent bacterial infection, and gram‐negative bacilli were the main pathogens. Invasive fungal infections (IFI) occurred in 20 (14.5%) patients with sAH and 3 (4.5%) with patients with DAC (P < 0.05). Multivariable regression showed that younger age, higher MELD, and corticosteroid therapy were independently associated with IFI. The 90‐day cumulative incidence of death in patients infected with sAH and patients infected with DAC was 46% and 41.5%, respectively (P = 0.43). Conclusions: Patients with sAH are more susceptible to develop infection than those with DAC. In life‐threatening forms of ALD, patients who were infected share a similar mortality rate. Corticosteroid treatment, not sAH, seems to be the main risk factor triggering IFI.
- 28 May 2021
- Published by Wolters Kluwer Health in Hepatology
- Vol. 74 (5) , 2714-2724
Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol‐Associated Liver Disease
Background and Aims: Infection is a major driver of mortality in patients with advanced alcohol‐associated liver disease (ALD). The epidemiology and clinical course of patients infected with life‐threatening forms of ALD, including severe alcohol‐associated hepatitis (sAH) and decompensated alcohol‐associated cirrhosis (DAC), and specific risk factors for infection remain mostly unknown. Approach and Results: In this observational study, we assessed all infectious episodes occurring within a 90‐day period from diagnosis in all consecutive patients with biopsy‐proven sAH (modified Maddrey’s discriminant function ≥ 32, Model for End‐Stage Liver Disease [MELD] ≥ 18) and DAC (MELD ≥ 18) without alcohol‐associated hepatitis in our tertiary hospital between 2003 and 2016. A total of 207 patients were included: 139 with sAH and 68 with DAC. One hundred seventeen (84%) patients with sAH and 41 (60%) patients with DAC experienced at least one infection episode at 90 days (P < 0.001). In multivariable analysis, factors associated with the development of infection were the presence of sAH and baseline MELD score. Bacterial infections represented the most common infection in the two groups, and only the MELD score was independently associated with the occurrence of bacterial infection. In both groups, pneumonia was the most prevalent bacterial infection, and gram‐negative bacilli were the main pathogens. Invasive fungal infections (IFI) occurred in 20 (14.5%) patients with sAH and 3 (4.5%) with patients with DAC (P < 0.05). Multivariable regression showed that younger age, higher MELD, and corticosteroid therapy were independently associated with IFI. The 90‐day cumulative incidence of death in patients infected with sAH and patients infected with DAC was 46% and 41.5%, respectively (P = 0.43). Conclusions: Patients with sAH are more susceptible to develop infection than those with DAC. In life‐threatening forms of ALD, patients who were infected share a similar mortality rate. Corticosteroid treatment, not sAH, seems to be the main risk factor triggering IFI.
- Top Cited PapersOpen Access
- 1 May 2021
- Published by Elsevier in Journal of Hepatology
- Vol. 74 (5) , 1097-1108
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
- 1 May 2021
- Published by Elsevier in Journal of Hepatology
- Vol. 74 (5) , 1097-1108
Top Cited PapersOpen AccessPREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
- 1 August 2018
- Published by Elsevier in Journal of Hepatology
- Vol. 69 (2) , 318-324
The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis
- 1 August 2018
- Published by Elsevier in Journal of Hepatology
- Vol. 69 (2) , 318-324
The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis
- 1 July 2018
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 50 (7) , E172-E174
Peroral endoscopic myotomy as a versatile approach to treating complex esophageal disorders
Since 2008, peroral endoscopic myotomy (POEM) has evolved as a technique for managing esophageal achalasia [1]. POEM has also recently emerged as a potential therapeutic tool in treating other esophageal motility disorders [2] [3], including Jackhammer esophagus and Zenker’s diverticulum [4]. However, for mid or lower esophageal diverticulum, the surgical treatment is still recommended, despite being associated with high morbidity. In this video case we report the application of the POEM technique as a therapeutic approach in a patient affected by Jackhammer esophagus, distal esophageal spasm, and a large distal esophageal diverticulum ([Fig. 1], [Fig. 2 a]). The aim of this POEM variation was to create a submucosal tunnel as a single access both to the diverticular septum, to perform septotomy, and to the esophageal wall muscle and lower esophageal sphincter (LES), in order to perform myotomy ([Fig. 3], [Video 1]). Video 1 A modified peroral endoscopic myotomy technique as a therapeutic approach for treating, with a single submucosal tunnel, a complex case combining Jackhammer esophagus, distal esophageal spasm, and a large distal esophageal diverticulum. Compared with the classical POEM procedure, five phases were defined. After mucosa incision and submucosal tunneling, the myotomy was performed as a hybrid technique. Initially, an anterograde section of the esophageal wall muscle was dissected, starting from the fibers below the diverticular septum, progressing downstream, and ending in the stomach, beyond the LES section. Next, a retrograde septotomy was performed, beginning from the most distal septal fibers and working toward the proximal ones. At the end, the tunnel entry was sealed using hemostatic clips. This case report shows that POEM is versatile, safe, effective ([Fig. 2 b]), and minimally invasive. Its evaluation as a therapeutic tool in patients having mid or distal esophageal symptomatic diverticulum, whether associated with motility disorders or not, should be encouraged. However, despite the low rate of overall morbidity and mortality reported for conventional POEM [5], it should be carefully customized to each specific case, in order to reduce the risks of potential complications. Endoscopy_UCTN_Code_TTT_1AO_2AN
- 1 July 2018
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 50 (7) , E172-E174
Peroral endoscopic myotomy as a versatile approach to treating complex esophageal disorders
Since 2008, peroral endoscopic myotomy (POEM) has evolved as a technique for managing esophageal achalasia [1]. POEM has also recently emerged as a potential therapeutic tool in treating other esophageal motility disorders [2] [3], including Jackhammer esophagus and Zenker’s diverticulum [4]. However, for mid or lower esophageal diverticulum, the surgical treatment is still recommended, despite being associated with high morbidity. In this video case we report the application of the POEM technique as a therapeutic approach in a patient affected by Jackhammer esophagus, distal esophageal spasm, and a large distal esophageal diverticulum ([Fig. 1], [Fig. 2 a]). The aim of this POEM variation was to create a submucosal tunnel as a single access both to the diverticular septum, to perform septotomy, and to the esophageal wall muscle and lower esophageal sphincter (LES), in order to perform myotomy ([Fig. 3], [Video 1]). Video 1 A modified peroral endoscopic myotomy technique as a therapeutic approach for treating, with a single submucosal tunnel, a complex case combining Jackhammer esophagus, distal esophageal spasm, and a large distal esophageal diverticulum. Compared with the classical POEM procedure, five phases were defined. After mucosa incision and submucosal tunneling, the myotomy was performed as a hybrid technique. Initially, an anterograde section of the esophageal wall muscle was dissected, starting from the fibers below the diverticular septum, progressing downstream, and ending in the stomach, beyond the LES section. Next, a retrograde septotomy was performed, beginning from the most distal septal fibers and working toward the proximal ones. At the end, the tunnel entry was sealed using hemostatic clips. This case report shows that POEM is versatile, safe, effective ([Fig. 2 b]), and minimally invasive. Its evaluation as a therapeutic tool in patients having mid or distal esophageal symptomatic diverticulum, whether associated with motility disorders or not, should be encouraged. However, despite the low rate of overall morbidity and mortality reported for conventional POEM [5], it should be carefully customized to each specific case, in order to reduce the risks of potential complications. Endoscopy_UCTN_Code_TTT_1AO_2AN
- 21 June 2018
- Published by Wiley in Liver International
- Vol. 38 (12) , 2228-2238
Long‐term outcome in patients with acute liver failure
Background & Aims: Acute liver failure patients who meet poor prognostic criteria have high early mortality without emergency liver transplantation. A recent study however, reported that patients that survive spontaneously have a poorer outcome compared with patients undergoing transplantation. In this single centre study, we aimed to confirm or refute this observation.Methods: Early survivors (acute liver failure patients who survived 90 days after the ICU admission) were assessed for long‐term outcomes in four distinctive cohorts, incorporating aetiology (Acetaminophen overdose or non‐Acetaminophen overdose), and management strategy (conservative or liver transplantation). Chi Squared or Fisher test were used to compare outcomes among the four cohorts (P < 0.05) and Kaplan–Meier curve (Log Rank test) to represent cumulative survival.Results: Two hundred consecutive acute liver failure patients between 1990 and 2014 were included; mean age 38.3, ±12.8, male 70, 35%. 124/200 (62%) early survivors were identified; 13/124 (10.5%) acetaminophen patients underwent transplantation and 48/124 (38.7%) survived spontaneously; 36/124 (29.0%) non‐acetaminophen underwent transplantation and 27/124 (21.8%) survived spontaneously. A total of 11/124 (8.9%) died subsequently (median survival 5.3± IQR 9.1), three spontaneous survivors and eight transplanted patients (P = 0.025); of the eight transplanted patients, six died of transplant related complications and two of suicide.Conclusion: The results of this study suggest that although liver transplantation is a life‐saving procedure for acute liver failure patients, they have a worse long‐term outcome compared with spontaneous survivors. Novel therapies to increase the percentage of spontaneous survivors are urgently needed.
- 21 June 2018
- Published by Wiley in Liver International
- Vol. 38 (12) , 2228-2238
Long‐term outcome in patients with acute liver failure
Background & Aims: Acute liver failure patients who meet poor prognostic criteria have high early mortality without emergency liver transplantation. A recent study however, reported that patients that survive spontaneously have a poorer outcome compared with patients undergoing transplantation. In this single centre study, we aimed to confirm or refute this observation.Methods: Early survivors (acute liver failure patients who survived 90 days after the ICU admission) were assessed for long‐term outcomes in four distinctive cohorts, incorporating aetiology (Acetaminophen overdose or non‐Acetaminophen overdose), and management strategy (conservative or liver transplantation). Chi Squared or Fisher test were used to compare outcomes among the four cohorts (P < 0.05) and Kaplan–Meier curve (Log Rank test) to represent cumulative survival.Results: Two hundred consecutive acute liver failure patients between 1990 and 2014 were included; mean age 38.3, ±12.8, male 70, 35%. 124/200 (62%) early survivors were identified; 13/124 (10.5%) acetaminophen patients underwent transplantation and 48/124 (38.7%) survived spontaneously; 36/124 (29.0%) non‐acetaminophen underwent transplantation and 27/124 (21.8%) survived spontaneously. A total of 11/124 (8.9%) died subsequently (median survival 5.3± IQR 9.1), three spontaneous survivors and eight transplanted patients (P = 0.025); of the eight transplanted patients, six died of transplant related complications and two of suicide.Conclusion: The results of this study suggest that although liver transplantation is a life‐saving procedure for acute liver failure patients, they have a worse long‐term outcome compared with spontaneous survivors. Novel therapies to increase the percentage of spontaneous survivors are urgently needed.